Method for minimally invasive, cell-selective laser therapy on the eye

Patent metadata

Field	Value
Publication number	US-2019117461-A1
Application number	US-201716090495-A
Country	US
Kind code	A1
Filing date	Apr 7, 2017
Priority date	Apr 8, 2016
Publication date	Apr 25, 2019
Grant date	—

Abstract

A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 μs are provided for selective therapies and pulse lengths ranging from 50 μs to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.

First claim

1 .- 17 . (canceled)

18 . A laser system for a minimally invasive, cell-selective laser therapy at the eye, comprising:
a frequency-doubled, continuously operating solid-state laser with a pumping source and a control unit; wherein the control unit is designed to regulate the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to 50 μs for selective therapies and individual pulses with pulse lengths ranging from 50 ns to continuously for coagulative or stimulating therapies, with an energy density that varies in dependence of the pulse length.

19 . The laser system according to claim 18 , wherein the solid-state laser generates spot sizes ranging between 50 μm and 100 μm that are used for the laser therapy, which are generated as one or more individual pulses and which are bundled in the form of patterns whose shape and spot distance are adjustable.

20 . The laser system according to claim 18 , wherein the control unit is designed to vary the pumping current of the pump source in such a way that the pulse lengths and thus the energy density of the individual pulses of an entire pattern or also of the individual pulses within a pattern are adjustable.

21 . The laser system according to the claim 18 , wherein the control unit controls the pulse lengths and thus the energy density of the individual pulses of an entire pattern or also of the individual pulses within a pattern are alternating.

22 . The laser system according to claim 18 , wherein the control unit comprises an operating menu with one or more predetermined parameter sets for different selective therapy forms in the eye.

23 . The laser system according to claim 22 , wherein the following parameters are taken into account in parameter sets of an operating menu of the control unit: spot size, spot distance, shape of the pattern, pulse length, energy density and number of pulses as well as repetition rate.

24 . The laser system according to claim 18 , wherein the solid-state laser system is structured to emit individual pulses with pulse lengths in arange of 50 ns-500 ns for selective laser trabeculoplasty, for selective retina therapy and for retina regeneration therapy.

25 . The laser system according to claim 24 wherein the solid-state laser system is structured to emit individual pulses in a range of 1 μs-50 μs, for selective laser trabeculoplasty, for selective retina therapy and for retina regeneration therapy.

26 . The laser system according to claim 24 wherein the solid-state laser system is structured to emit individual pulses in a range of 5 μs for selective laser trabeculoplasty, for selective retina therapy and for retina regeneration therapy.

27 . The laser system according to claim 24 , wherein the control unit controls energy density of an individual pulse at pulse lengths ranging between 50 ns and 500 ns is >50 mJ/cm 2 and at pulse lengths ranging between 1 μs and 50 μs>500 mJ/cm 2 .

28 . The laser system according to claim 24 wherein the control unit controls spot sizes for an individual pulse in a range of 50 μm to 100 μm for selective laser trabeculoplasty, laser spots being placed next to each other in a dense packing, in particular as a square spot.

29 . The laser system according to claim 24 , wherein the control unit controls laser spots being placed next to each other in the dense packing as a square spot.

30 . The laser system according to claim 24 , wherein the control unit controls the laser to apply maximum patterns of 400×400 μm 2 are generated in the trabecular meshwork.

31 . The laser system according to claim 27 , wherein the control unit controls the laser to apply a pattern composed of square laser spots and that it is preferably composed as an octagonal pattern made of 52 laser spots.

32 . The laser system according to claim 27 , wherein the control unit controls the laser to apply an octagonal pattern made of 52 square laser spots.

33 . The laser system according to claim 24 , wherein the solid-state laser is structured to emit a laser wavelength in the green or yellow spectral range that selectively destroys lipofuscin at the retina.

34 . The laser system according to claim 24 , wherein the solid-state laser is structured to emit a laser wavelength of 532 nm, 561 nm, 577 nm or 586 nm, that selectively destroys lipofuscin at the retina.

35 . The laser system according to claim 18 , wherein the solid-state laser is structured to emit individual pulses with pulse lengths in the ms-range for the thermal millisecond laser coagulation.

36 . The laser system according to claim 18 , wherein the control unit is structured to calculate a center size of a damage zone with a lateral and axial expansion from a size of an optical spot at a treatment location, a pulse length, an energy density and to thereby take into account a magnification of a contact glass that was used.

37 . The laser system according to claim 36 , wherein the control unit is structured to select parameter sets for the solid-state laser from the ascertained center size of a damage area.

38 . The laser system according to claim 37 , wherein the control unit is structured to determine the size of an irreversibly damaged center in order to then select a spot distance of the individual pulses in such a way that no overlapping of irreversible damages occurs.

39 . The laser system according to claim 37 , wherein the control unit is structured to regulate additional distances between the irreversibly damaged center sizes.

40 . The laser system according to the claims 18 , wherein the control unit is structured to measure a course of a temperature by opto-acoustic detection and to use the temperature as a therapy criterion.

Assignees

• Zeiss Carl Meditec Ag

Inventors

• Dick Manfred
• Kunath-Fandrei Gerald
• Denner René
• Wurlitzer Thomas

Classifications

• A61F2009/00897

  Scanning mechanisms or algorithms · CPC title

• A61F2009/00863

  Retina · CPC title

• A61F2009/00868

  Ciliary muscles or trabecular meshwork · CPC title

• A61F9/00821 Primary

  for coagulation · CPC title

• A61F9/009

  Auxiliary devices making contact with the eyeball and coupling in laser light, {e.g. goniolenses (apparatus for eye examination A61B3/0008)} · CPC title